We focus on the development of original high-tech technologies in the field of precision medicine, with an emphasis on the isolation, enrichment, and functional application of rare cells. Leveraging our self-developed next-generation inertial microfluidic platform, we are able to obtain high-purity rare cells of various types — including tumor cells, immune cells, and stem cells — from blood, cerebrospinal fluid, and other body fluid samples without the need for antibody labeling, while preserving their morphological and functional integrity. We firmly believe that the future of precision medicine begins with a deep understanding of the smallest units of life.